Literature DB >> 1898254

Diagnostic criteria for multiple sclerosis research involving multiply affected families.

D E Goodkin1, T H Doolittle, S S Hauser, R M Ransohoff, A D Roses, R A Rudick.   

Abstract

Existing diagnostic criteria for multiple sclerosis present significant limitations when assessing multiplex families for three reasons: (1) restricting age of onset to 10 to 50 years is likely to exclude 10% of patients known to have a later onset, (2) diagnoses based on subjective information can potentially result in a false-positive diagnosis, and (3) including progressive myelopathies occurring within families, particularly when highly symmetrical, may result in the improper inclusion of genetically determined neurological diseases such as familial spastic paraparesis. The validity of any molecular genetic approach for determining disease susceptibility critically depends on diagnostic accuracy. We present adapted diagnostic criteria that address each of these diagnostic pitfalls unique to multiplex multiple sclerosis family research.

Entities:  

Mesh:

Year:  1991        PMID: 1898254     DOI: 10.1001/archneur.1991.00530200041016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

1.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

2.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.

Authors:  Pierre-Antoine Gourraud; Joseph P McElroy; Stacy J Caillier; Britt A Johnson; Adam Santaniello; Stephen L Hauser; Jorge R Oksenberg
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

3.  IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Authors:  Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

Review 4.  Genetics and pathogenesis of multiple sclerosis.

Authors:  R L Zuvich; J L McCauley; M A Pericak-Vance; J L Haines
Journal:  Semin Immunol       Date:  2009-09-22       Impact factor: 11.130

5.  Genetic burden in multiple sclerosis families.

Authors:  N Isobe; V Damotte; V Lo Re; M Ban; D Pappas; L Guillot-Noel; I Rebeix; A Compston; T Mack; W Cozen; B Fontaine; S L Hauser; J R Oksenberg; S Sawcer; P-A Gourraud
Journal:  Genes Immun       Date:  2013-08-01       Impact factor: 2.676

6.  Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.

Authors:  Margaret A Pericak-Vance; Jackie B Rimmler; Jonathan L Haines; Melissa E Garcia; Jorge R Oksenberg; Lisa F Barcellos; Robin Lincoln; Stephen L Hauser; Isabelle Cournu-Rebeix; Ariele Azoulay-Cayla; Olivier Lyon-Caen; Bertrand Fontaine; Emmanuelle Duhamel; Helene Coppin; David Brassat; Marie-Paule Roth; Michel Clanet; Mehdi Alizadeh; Jacqueline Yaouanq; Erwann Quelvennec; Gilbert Semana; Gilles Edan; Marie-Claude Babron; Emmanuelle Genin; Francoise Clerget-Darpoux
Journal:  Neurogenetics       Date:  2003-11-01       Impact factor: 2.660

7.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.

Authors:  R Shimonkevitz; C Colburn; J A Burnham; R S Murray; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

8.  HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.

Authors:  L F Barcellos; J R Oksenberg; A B Begovich; E R Martin; S Schmidt; E Vittinghoff; D S Goodin; D Pelletier; R R Lincoln; P Bucher; A Swerdlin; M A Pericak-Vance; J L Haines; S L Hauser
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

9.  Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings.

Authors:  P J Tienari; O Salonen; J Wikström; L Valanne; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

10.  Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis.

Authors:  J L McCauley; R L Zuvich; Y Bradford; S J Kenealy; N Schnetz-Boutaud; S G Gregory; S L Hauser; J R Oksenberg; D P Mortlock; M A Pericak-Vance; J L Haines
Journal:  Genes Immun       Date:  2009-07-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.